Successful generics companies understand, that effective business development & licensing are essential to sustain major market leadership. The whole area of licensing, partnering and co-development is growing and this surge is predicted to continue.

 

Are you able to unlock licensing potential?

Give your licensing strategy the best chance of success! Join us at this event and together with the experts from the generics industry benchmark their direct experiences with high level licensing deals and analyse the impact of regulatory environment on generics, including the authorities’ perspective.

 

 

• Director In-Licensing, Ranbaxy, India
• Head of Unit Regulatory Affairs, Bfarm, Germany
• Out-Licensing Manager, Glenmark Pharma, UK
• Executive Vice President of Third-party sales, Actavis, Iceland
• Business Development Director, Akrikhin Pharmaceutical, Russia
• Director, Efarmes, Spain
• R&D Director, Abdi Ibrahim, Turkey

 

 

Optimize your licensing activities

 

Targeting of potential licensing opportunities

 

Designing a win – win licensing deal

 

Case studies on negotiating a license

 

Leveraging value vs costs/risks associated with licensing deals

 

Regulatory aspects and its impact on the licensing strategy

 

Looking for API sourcing partners in India and China

 

Overcoming obstacles of in-licensing & out-licensing

 

Emerging trends in licensing in generics

 

 

Generic and Biogeneric companies:

 

CEOs, Chief Licensing Officers, Vice Presidents, Senior Executives, Heads, Directors and Managers of: Business Development and Licensing, Licensing, Technology Licensing, Patent Licensing, Product Licensing & Development, Licensing & External Research, Regulatory Affairs, Strategic Planning, Corporate Development, Commercial and Logistics Operations